Is adjunctive balloon postdilatation necessary with drug-eluting stents? One center experience in Chinese patients

Chinese Medical Journal

Volumn 121, Issue 6, 2008, Pages 513-517

  Gao, Zhan ^a   Yang, Yue Jin ^a   Xu, Bo ^a   Chen, Ji Lin ^a   Qiao, Shu Bin ^a   Yao, Min ^a   Chen, Juc ^a   Wu, Yong Jian ^a   Liu, Hai Bo ^a   Dai, Jun ^a   Yuan, Jin Qing ^a   Li, Jian Jun ^a   Gao, Run Lin ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Drug eluting stent; Percutaneous coronary intervention; Postdilatation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; VASODILATATION;

EID: 41649090185     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200803020-00009     Document Type: Article

References (16)

1. Moussa I, Moses J, Di Mario C, Albiero R, De Gregorio J, Adamian M, et al. Does the specific intravascular ultrasound criteria used to optimize stent expansion have an impact on the probability of stent restenosis? Am J Cardiol 1999; 83: 1012-1017.
2. Russo RJ, Attubato MJ, Davidson CJ, Russo RJ, Cloutier DA, Schatz RA, et al. Angiography versus intravascular ultrasound-directed stent placement: final results from AVID. Circulation 1999; 100 Suppl 1: I234.
3. Fitzgerald PJ, Oshima A, Hayase M, Metz JA, Bailey SR, Baim DS, et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 2000; 102: 523-530.
4. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel angioplasty prognosis study group. Circulation 1990; 82: 1193-1202.
5. Hehrlein C, DeVries JJ, Wood TA, Haller SD, Arab A, Kloostra AC, et al. Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: a quantitative coronary analysis of Duet and NIR stent implantation. Catheter Cardiovase Interven 2001, 53: 474-478.
6. Costa JR Jr, Mintz GS, Carlier SCT, Costa RA, Fujii K, Sano K, et al. Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol 2005; 96: 74-78.
7. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004, 109: 1366-1370.
8. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 2004, 43: 1959-1963.
9. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004; 110: 3430-3434.
10. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004; 109: 1942-1947.
11. Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 2005; 45: 1180-1185.
12. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
13. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C Mann JT, et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
14. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis. J Am Coll Cardiol 2005; 45: 941-946.
15. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic CT, et al. Incidence, predictors, and outcome o thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
16. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-998.